Share:
LOUISVILLE, Ky., May 06, 2021 (GLOBE NEWSWIRE) Churchill Downs Incorporated ( CDI or Company ) (NASDAQ:CHDN) announced today that Katherine Armstrong has been hired as Vice President of Culture (Diversity, Equity and Inclusion) for the Company. The new role will report directly to Bill Carstanjen, Chief Executive Officer of CDI.
As the Vice President of Culture, Armstrong will be part of the senior leadership team of CDI and will lead the Company s efforts to expand its strategic vision as part of the Company s core mission and values to systemically advance a culture of diversity, equity and inclusion. Armstrong will develop and drive diversity initiatives and create opportunities to share best practices across the business segments.
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended March 31, 2021. The Company reported first quarter net sales of $1.847 billion, an increase of 3.6% over the prior year period, and an increase of 0.8% on a constant currency basis. Net earnings for the first quarter were $198.1 million, or $359.1 million on an adjusted basis.
Regulatory and white collar crime partner joins political & legal advisory firm Avonhurst
Media
LONDON – Avonhurst today announced it will be joined by former Skadden, Arps lawyer Audrey Koh. Koh joins the firm from Womble Bond Dickinson, where she was partner and Head of White Collar Crime and Investigations. Previously she spent 11 years at Skadden in London, having also worked in that firm’s Singapore office. Based in London, Avonhurst provides advisory services, transactional legal services and capital services to its sophisticated capital clients.
Audrey Koh
Koh has extensive regulatory experience, spanning investigations and compliance matters focused on the Foreign Corrupt Practices Act (FCPA), UK Bribery Act (UKBA), sanctions and wider financial crime, including having worked in-house as Director (Legal and Compliance) at Kerogen Capital (a Financial Conduct Authority (FCA)-Approved person role) and on a 16-month secondment to the Serious Fraud Office (SFO).
Message :
Required fields
WARSAW, Ind., May 4, 2021 /PRNewswire/ Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended March 31, 2021. The Company reported first quarter net sales of $1.847 billion, an increase of 3.6% over the prior year period, and an increase of 0.8% on a constant currency basis. Net earnings for the first quarter were $198.1 million, or $359.1 million on an adjusted basis.
Diluted earnings per share were $0.94 for the first quarter. Adjusted diluted earnings per share were $1.71 for the first quarter, an increase of 0.6% over the prior year period. Our performance was stronger than we anticipated in the first quarter, as we saw signs of the pandemic beginning to subside across many regions toward the end of the quarter driven by acceleration of vaccine rollout. As we move into the second quarter, we expect that momentum to continue and believe we are well-positioned to meet the needs of our